モルフォリノ (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "モルフォリノ" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

3semanticscholar.org

11^th place

1,537^th place

447^th place

1,043^rd place

5^th place

19^th place

18^th place

107^th place

1gene-tools.com

low place

low place

5,636^th place

low place

102^nd place

78^th place

doi.org

“Morpholino oligos: making sense of antisense?”. Developmental Biology 243 (2): 209–14. (March 2002). doi:10.1006/dbio.2001.0565. PMID 11884031.
“Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown”. Genesis 30 (3): 154–6. (July 2001). doi:10.1002/gene.1053. PMID 11477696.
“Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development”. PLOS Biology 5 (8): e203. (August 2007). doi:10.1371/journal.pbio.0050203. PMC 1925136. PMID 17676975.
(英語) Morpholino Oligomers. Methods in Molecular Biology. 1565. Humana Press (Springer). (2017). pp. 284. doi:10.1007/978-1-4939-6817-6. ISBN 978-1-4939-6815-2
“In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus”. Antimicrobial Agents and Chemotherapy 51 (7): 2470–82. (July 2007). doi:10.1128/AAC.00069-07. PMC 1913242. PMID 17485503.
“Induced dystrophin exon skipping in human muscle explants”. Neuromuscular Disorders 16 (9–10): 583–90. (October 2006). doi:10.1016/j.nmd.2006.05.017. PMID 16919955.
Roshmi, R. R.; Yokota, T. (October 2019). “Viltolarsen for the treatment of Duchenne muscular dystrophy”. Drugs of Today 55 (10): 627–639. doi:10.1358/dot.2019.55.10.3045038. ISSN 1699-3993. PMID 31720560.
Shirley, Matt (May 2021). “Casimersen: First Approval”. Drugs 81 (7): 875–879. doi:10.1007/s40265-021-01512-2. ISSN 1179-1950. PMID 33861387.
“Invention and Early History of Morpholinos: From Pipe Dream to Practical Products” (英語). Morpholino Oligomers. Methods in Molecular Biology. 1565. Humana Press (Springer). (2017). pp. 1–15. doi:10.1007/978-1-4939-6817-6_1. ISBN 978-1-4939-6817-6. PMID 28364229
“Morpholino antisense oligomers: design, preparation, and properties”. Antisense & Nucleic Acid Drug Development 7 (3): 187–95. (June 1997). doi:10.1089/oli.1.1997.7.187. PMID 9212909.
“Morpholino antisense oligomers: the case for an RNase H-independent structural type”. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1489 (1): 141–58. (December 1999). doi:10.1016/S0167-4781(99)00150-5. PMID 10807004.
“Effective targeted gene 'knockdown' in zebrafish”. Nature Genetics 26 (2): 216–20. (October 2000). doi:10.1038/79951. PMID 11017081.
“Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach”. Developmental Biology 222 (1): 124–34. (June 2000). doi:10.1006/dbio.2000.9720. PMID 10885751.
“SpKrl: a direct target of beta-catenin regulation required for endoderm differentiation in sea urchin embryos”. Development 128 (3): 365–75. (February 2001). doi:10.1242/dev.128.3.365. PMID 11152635.
“The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos”. Development 128 (8): 1467–79. (April 2001). doi:10.1242/dev.128.8.1467. PMID 11262245.
“Achieving efficient delivery of morpholino oligos in cultured cells”. Genesis 30 (3): 94–102. (July 2001). doi:10.1002/gene.1039. PMID 11477682.
“Endo-Porter: a novel reagent for safe, effective delivery of substances into cells”. Annals of the New York Academy of Sciences 1058 (1): 62–75. (November 2005). Bibcode: 2005NYASA1058...62S. doi:10.1196/annals.1359.012. PMID 16394126.
“Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues”. BioTechniques 45 (6): 613–4, 616, 618 passim. (December 2008). doi:10.2144/000113005. PMID 19238792.
“Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo”. The Journal of Antimicrobial Chemotherapy 72 (3): 782–790. (March 2017). doi:10.1093/jac/dkw476. PMC 5890718. PMID 27999041.
“Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements”. Human Molecular Genetics 13 (20): 2409–20. (October 2004). doi:10.1093/hmg/ddh272. PMID 15333583.
“Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides”. Human Mutation 27 (5): 420–6. (May 2006). doi:10.1002/humu.20303. PMID 16550551.
“Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos”. Biochemical and Biophysical Research Communications 358 (2): 521–7. (June 2007). doi:10.1016/j.bbrc.2007.04.172. PMID 17493584.
“Splicing segregation: the minor spliceosome acts outside the nucleus and controls cell proliferation”. Cell 131 (4): 718–29. (November 2007). doi:10.1016/j.cell.2007.09.043. PMID 18022366.
“Substrate requirements for let-7 function in the developing zebrafish embryo”. Nucleic Acids Research 32 (21): 6284–91. (2004). doi:10.1093/nar/gkh968. PMC 535676. PMID 15585662.
“Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate”. Nature Genetics 39 (2): 259–63. (February 2007). doi:10.1038/ng1953. PMC 3982799. PMID 17220889.
“Revealing details: whole mount microRNA in situ hybridization protocol for zebrafish embryos and adult tissues”. Biology Open 1 (6): 566–9. (June 2012). doi:10.1242/bio.2012810. PMC 3509442. PMID 23213449.
“Exogenous control of mammalian gene expression through modulation of RNA self-cleavage”. Nature 431 (7007): 471–6. (September 2004). Bibcode: 2004Natur.431..471Y. doi:10.1038/nature02844. PMID 15386015.
“Targeted 'knockdown' of spliceosome function in mammalian cells”. Nucleic Acids Research 33 (4): e41. (February 2005). doi:10.1093/nar/gni041. PMC 549580. PMID 15731334.
“Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides”. RNA 10 (10): 1653–61. (October 2004). doi:10.1261/rna.7810204. PMC 1370650. PMID 15383681.
“Steric antisense inhibition of AMPA receptor Q/R editing reveals tight coupling to intronic editing sites and splicing”. Nucleic Acids Research 41 (2): 1113–23. (January 2013). doi:10.1093/nar/gks1044. PMC 3553965. PMID 23172291.
“Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation”. Molecular Cell 43 (6): 927–39. (September 2011). doi:10.1016/j.molcel.2011.08.009. PMC 3781938. PMID 21925381.
“Participation of Xenopus Elr-type proteins in vegetal mRNA localization during oogenesis”. The Journal of Biological Chemistry 284 (30): 19982–92. (July 2009). doi:10.1074/jbc.M109.009928. PMC 2740424. PMID 19458392.
“A primer for morpholino use in zebrafish”. Zebrafish 6 (1): 69–77. (March 2009). doi:10.1089/zeb.2008.0555. PMC 2776066. PMID 19374550.
“Quantitative assessment of the knockdown efficiency of morpholino antisense oligonucleotides in zebrafish embryos using a luciferase assay”. Genesis 46 (1): 1–7. (January 2008). doi:10.1002/dvg.20361. PMID 18196596.
“Guidelines for morpholino use in zebrafish”. PLOS Genetics 13 (10): e1007000. (October 2017). doi:10.1371/journal.pgen.1007000. PMC 5648102. PMID 29049395.
“Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation”. Antisense & Nucleic Acid Drug Development 6 (4): 267–72. (1996). doi:10.1089/oli.1.1996.6.267. PMID 9012862.
“Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells”. Bioconjugate Chemistry 18 (1): 50–60. (2007). doi:10.1021/bc060138s. PMID 17226957.
“Morphant technology in model developmental systems”. Genesis 30 (3): 89–93. (July 2001). doi:10.1002/gene.1038. PMID 11477681.
“p53 activation by knockdown technologies”. PLOS Genetics 3 (5): e78. (May 2007). doi:10.1371/journal.pgen.0030078. PMC 1877875. PMID 17530925.
“Microinjection of zebrafish embryos to analyze gene function”. Journal of Visualized Experiments 9 (25). (March 2009). doi:10.3791/1115. PMC 2762901. PMID 19274045.
“Electroporation of DNA, RNA, and morpholinos into zebrafish embryos”. Methods 39 (3): 207–11. (July 2006). doi:10.1016/j.ymeth.2005.12.009. hdl:10533/178089. PMID 16837210.
“Optimizing electroporation conditions for intracellular delivery of Morpholino antisense oligonucleotides directed against the hepatitis C virus internal ribosome entry site”. Antisense Therapeutics. 106. (2004). 309–22. doi:10.1385/1-59259-854-4:309. ISBN 978-1-59259-854-0. PMID 15375324
“A simple method for delivering morpholino antisense oligos into the cytoplasm of cells”. Antisense & Nucleic Acid Drug Development 6 (3): 169–75. (1996). doi:10.1089/oli.1.1996.6.169. PMID 8915501.
“Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide”. The Journal of Gene Medicine 8 (2): 207–16. (February 2006). doi:10.1002/jgm.838. PMID 16285002.
“Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model”. Journal of the American College of Cardiology 39 (10): 1686–91. (May 2002). doi:10.1016/S0735-1097(02)01830-2. PMID 12020498.
“Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents”. Journal of Controlled Release 116 (3): 304–13. (December 2006). doi:10.1016/j.jconrel.2006.09.011. PMID 17097177.
“Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models”. Journal of Virology 81 (11): 5637–48. (June 2007). doi:10.1128/JVI.02360-06. PMC 1900280. PMID 17344287.
“Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate”. Bioconjugate Chemistry 18 (4): 1325–31. (2007). doi:10.1021/bc070060v. PMID 17583927.
“Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo”. Bioconjugate Chemistry 19 (7): 1464–70. (July 2008). doi:10.1021/bc8001437. PMID 18564870.
“Gene knockdowns in adult animals: PPMOs and vivo-morpholinos”. Molecules 14 (3): 1304–23. (March 2009). doi:10.3390/molecules14031304. PMC 6253989. PMID 19325525.

fda.gov

“Press Announcements - FDA grants accelerated approval to first drug for Duchenne muscular dystrophy”. Food and Drug Administration (2019年9月10日). 2023年10月7日閲覧。
Commissioner, Office of the (2019年12月12日). “FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation” (英語). FDA. 2019年12月14日閲覧。

gene-tools.com

“Guide for Morpholino Users: Toward Therapeutics”. J Drug Discov Develop and Deliv 3 (2): 1023. (2016).

handle.net

hdl.handle.net

“Electroporation of DNA, RNA, and morpholinos into zebrafish embryos”. Methods 39 (3): 207–11. (July 2006). doi:10.1016/j.ymeth.2005.12.009. hdl:10533/178089. PMID 16837210.

harvard.edu

ui.adsabs.harvard.edu

“Endo-Porter: a novel reagent for safe, effective delivery of substances into cells”. Annals of the New York Academy of Sciences 1058 (1): 62–75. (November 2005). Bibcode: 2005NYASA1058...62S. doi:10.1196/annals.1359.012. PMID 16394126.
“Exogenous control of mammalian gene expression through modulation of RNA self-cleavage”. Nature 431 (7007): 471–6. (September 2004). Bibcode: 2004Natur.431..471Y. doi:10.1038/nature02844. PMID 15386015.

newatlas.com

“New molecule knocks out superbugs' immunity to antibiotics”. newatlas.com (2017年1月20日). 2017年1月25日閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

“Morpholino oligos: making sense of antisense?”. Developmental Biology 243 (2): 209–14. (March 2002). doi:10.1006/dbio.2001.0565. PMID 11884031.
“Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown”. Genesis 30 (3): 154–6. (July 2001). doi:10.1002/gene.1053. PMID 11477696.
“Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development”. PLOS Biology 5 (8): e203. (August 2007). doi:10.1371/journal.pbio.0050203. PMC 1925136. PMID 17676975.
“Antibacterial antisense”. Current Opinion in Molecular Therapeutics 7 (2): 109–13. (April 2005). PMID 15844617.
“In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus”. Antimicrobial Agents and Chemotherapy 51 (7): 2470–82. (July 2007). doi:10.1128/AAC.00069-07. PMC 1913242. PMID 17485503.
“Induced dystrophin exon skipping in human muscle explants”. Neuromuscular Disorders 16 (9–10): 583–90. (October 2006). doi:10.1016/j.nmd.2006.05.017. PMID 16919955.
Roshmi, R. R.; Yokota, T. (October 2019). “Viltolarsen for the treatment of Duchenne muscular dystrophy”. Drugs of Today 55 (10): 627–639. doi:10.1358/dot.2019.55.10.3045038. ISSN 1699-3993. PMID 31720560.
Shirley, Matt (May 2021). “Casimersen: First Approval”. Drugs 81 (7): 875–879. doi:10.1007/s40265-021-01512-2. ISSN 1179-1950. PMID 33861387.
“Invention and Early History of Morpholinos: From Pipe Dream to Practical Products” (英語). Morpholino Oligomers. Methods in Molecular Biology. 1565. Humana Press (Springer). (2017). pp. 1–15. doi:10.1007/978-1-4939-6817-6_1. ISBN 978-1-4939-6817-6. PMID 28364229
“Morpholino antisense oligomers: design, preparation, and properties”. Antisense & Nucleic Acid Drug Development 7 (3): 187–95. (June 1997). doi:10.1089/oli.1.1997.7.187. PMID 9212909.
“Morpholino antisense oligomers: the case for an RNase H-independent structural type”. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1489 (1): 141–58. (December 1999). doi:10.1016/S0167-4781(99)00150-5. PMID 10807004.
“Effective targeted gene 'knockdown' in zebrafish”. Nature Genetics 26 (2): 216–20. (October 2000). doi:10.1038/79951. PMID 11017081.
“Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach”. Developmental Biology 222 (1): 124–34. (June 2000). doi:10.1006/dbio.2000.9720. PMID 10885751.
“SpKrl: a direct target of beta-catenin regulation required for endoderm differentiation in sea urchin embryos”. Development 128 (3): 365–75. (February 2001). doi:10.1242/dev.128.3.365. PMID 11152635.
“The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos”. Development 128 (8): 1467–79. (April 2001). doi:10.1242/dev.128.8.1467. PMID 11262245.
“Achieving efficient delivery of morpholino oligos in cultured cells”. Genesis 30 (3): 94–102. (July 2001). doi:10.1002/gene.1039. PMID 11477682.
“Endo-Porter: a novel reagent for safe, effective delivery of substances into cells”. Annals of the New York Academy of Sciences 1058 (1): 62–75. (November 2005). Bibcode: 2005NYASA1058...62S. doi:10.1196/annals.1359.012. PMID 16394126.
“Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues”. BioTechniques 45 (6): 613–4, 616, 618 passim. (December 2008). doi:10.2144/000113005. PMID 19238792.
“Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo”. The Journal of Antimicrobial Chemotherapy 72 (3): 782–790. (March 2017). doi:10.1093/jac/dkw476. PMC 5890718. PMID 27999041.
“Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements”. Human Molecular Genetics 13 (20): 2409–20. (October 2004). doi:10.1093/hmg/ddh272. PMID 15333583.
“Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides”. Human Mutation 27 (5): 420–6. (May 2006). doi:10.1002/humu.20303. PMID 16550551.
“Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos”. Biochemical and Biophysical Research Communications 358 (2): 521–7. (June 2007). doi:10.1016/j.bbrc.2007.04.172. PMID 17493584.
“Splicing segregation: the minor spliceosome acts outside the nucleus and controls cell proliferation”. Cell 131 (4): 718–29. (November 2007). doi:10.1016/j.cell.2007.09.043. PMID 18022366.
“Substrate requirements for let-7 function in the developing zebrafish embryo”. Nucleic Acids Research 32 (21): 6284–91. (2004). doi:10.1093/nar/gkh968. PMC 535676. PMID 15585662.
“Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate”. Nature Genetics 39 (2): 259–63. (February 2007). doi:10.1038/ng1953. PMC 3982799. PMID 17220889.
“Revealing details: whole mount microRNA in situ hybridization protocol for zebrafish embryos and adult tissues”. Biology Open 1 (6): 566–9. (June 2012). doi:10.1242/bio.2012810. PMC 3509442. PMID 23213449.
“Exogenous control of mammalian gene expression through modulation of RNA self-cleavage”. Nature 431 (7007): 471–6. (September 2004). Bibcode: 2004Natur.431..471Y. doi:10.1038/nature02844. PMID 15386015.
“Targeted 'knockdown' of spliceosome function in mammalian cells”. Nucleic Acids Research 33 (4): e41. (February 2005). doi:10.1093/nar/gni041. PMC 549580. PMID 15731334.
“Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides”. RNA 10 (10): 1653–61. (October 2004). doi:10.1261/rna.7810204. PMC 1370650. PMID 15383681.
“Steric antisense inhibition of AMPA receptor Q/R editing reveals tight coupling to intronic editing sites and splicing”. Nucleic Acids Research 41 (2): 1113–23. (January 2013). doi:10.1093/nar/gks1044. PMC 3553965. PMID 23172291.
“Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation”. Molecular Cell 43 (6): 927–39. (September 2011). doi:10.1016/j.molcel.2011.08.009. PMC 3781938. PMID 21925381.
“Participation of Xenopus Elr-type proteins in vegetal mRNA localization during oogenesis”. The Journal of Biological Chemistry 284 (30): 19982–92. (July 2009). doi:10.1074/jbc.M109.009928. PMC 2740424. PMID 19458392.
“A primer for morpholino use in zebrafish”. Zebrafish 6 (1): 69–77. (March 2009). doi:10.1089/zeb.2008.0555. PMC 2776066. PMID 19374550.
“Quantitative assessment of the knockdown efficiency of morpholino antisense oligonucleotides in zebrafish embryos using a luciferase assay”. Genesis 46 (1): 1–7. (January 2008). doi:10.1002/dvg.20361. PMID 18196596.
“Guidelines for morpholino use in zebrafish”. PLOS Genetics 13 (10): e1007000. (October 2017). doi:10.1371/journal.pgen.1007000. PMC 5648102. PMID 29049395.
“Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation”. Antisense & Nucleic Acid Drug Development 6 (4): 267–72. (1996). doi:10.1089/oli.1.1996.6.267. PMID 9012862.
“Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells”. Bioconjugate Chemistry 18 (1): 50–60. (2007). doi:10.1021/bc060138s. PMID 17226957.
“Morphant technology in model developmental systems”. Genesis 30 (3): 89–93. (July 2001). doi:10.1002/gene.1038. PMID 11477681.
“p53 activation by knockdown technologies”. PLOS Genetics 3 (5): e78. (May 2007). doi:10.1371/journal.pgen.0030078. PMC 1877875. PMID 17530925.
“Microinjection of zebrafish embryos to analyze gene function”. Journal of Visualized Experiments 9 (25). (March 2009). doi:10.3791/1115. PMC 2762901. PMID 19274045.
“Electroporation of DNA, RNA, and morpholinos into zebrafish embryos”. Methods 39 (3): 207–11. (July 2006). doi:10.1016/j.ymeth.2005.12.009. hdl:10533/178089. PMID 16837210.
“Optimizing electroporation conditions for intracellular delivery of Morpholino antisense oligonucleotides directed against the hepatitis C virus internal ribosome entry site”. Antisense Therapeutics. 106. (2004). 309–22. doi:10.1385/1-59259-854-4:309. ISBN 978-1-59259-854-0. PMID 15375324
“A simple method for delivering morpholino antisense oligos into the cytoplasm of cells”. Antisense & Nucleic Acid Drug Development 6 (3): 169–75. (1996). doi:10.1089/oli.1.1996.6.169. PMID 8915501.
“Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide”. The Journal of Gene Medicine 8 (2): 207–16. (February 2006). doi:10.1002/jgm.838. PMID 16285002.
“Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model”. Journal of the American College of Cardiology 39 (10): 1686–91. (May 2002). doi:10.1016/S0735-1097(02)01830-2. PMID 12020498.
“Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents”. Journal of Controlled Release 116 (3): 304–13. (December 2006). doi:10.1016/j.jconrel.2006.09.011. PMID 17097177.
“Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models”. Journal of Virology 81 (11): 5637–48. (June 2007). doi:10.1128/JVI.02360-06. PMC 1900280. PMID 17344287.
“Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate”. Bioconjugate Chemistry 18 (4): 1325–31. (2007). doi:10.1021/bc070060v. PMID 17583927.
“Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo”. Bioconjugate Chemistry 19 (7): 1464–70. (July 2008). doi:10.1021/bc8001437. PMID 18564870.
“Gene knockdowns in adult animals: PPMOs and vivo-morpholinos”. Molecules 14 (3): 1304–23. (March 2009). doi:10.3390/molecules14031304. PMC 6253989. PMID 19325525.

ncbi.nlm.nih.gov

semanticscholar.org

worldcat.org

search.worldcat.org

Roshmi, R. R.; Yokota, T. (October 2019). “Viltolarsen for the treatment of Duchenne muscular dystrophy”. Drugs of Today 55 (10): 627–639. doi:10.1358/dot.2019.55.10.3045038. ISSN 1699-3993. PMID 31720560.
Shirley, Matt (May 2021). “Casimersen: First Approval”. Drugs 81 (7): 875–879. doi:10.1007/s40265-021-01512-2. ISSN 1179-1950. PMID 33861387.